Taxol acquisition costs vary from 15%-23% below AWP, IG market survey finds.
Executive Summary
TAXOL ACQUISITION COSTS RANGE FROM 14.9%-23.2% BELOW AWP, IG reports, based on a survey of seven wholesalers and seven group purchasing organizations to determine the appropriateness of Medicare reimbursement rates for 22 drugs covered by the program. Bristol-Myers Squibb's anticancer agent Taxol (paclitaxel) carries a list price of $182.63 per vial AWP, according to the Red Book. The lowest price found by the HHS Inspector General was $140.26 per vial, and the highest price was $155.43 per vial.